Tilg, Herbert
Innsbruck Medical University · Universität Innsbruck
51 papers on CoChatORCID 0000-0002-4235-2579
Most cited papers
- Verified
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 2,548
- Verified
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut
Gut microbiota and healthOral microbiology and periodontitis research
Cited by 2,388
- Verified
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology
Gastrointestinal motility and disordersGut microbiota and health
Cited by 1,755
- Verified
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 1,207
- Verified
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology
Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases
Cited by 1,089
- Verified
NAFLD and diabetes mellitus
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,002
- Verified
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation
Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases
Cited by 860
- Verified
Microbiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut
Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases
Cited by 853
- Verified
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism
Gut microbiota and healthLiver Disease and Transplantation
Cited by 843
- Verified
A guiding map for inflammation
Netea, M. G., Balkwill, F., Chonchol, M., Cominelli, F., Donath, M. Y., Giamarellos-Bourboulis, E. J., Golenbock, D., Gresnigt, M. S., Heneka, M. T., Hoffman, H. M., et al. (2017) · Nature Immunology
Immune Response and InflammationInflammation biomarkers and pathways
Cited by 831
- Verified
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood
Cytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and Therapies
Cited by 817
- Verified
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine
Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism
Cited by 779
- Verified
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell
Gut microbiota and healthColorectal Cancer Treatments and Studies
Cited by 777
- Verified
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood
Platelet Disorders and TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment
Cited by 667
- Verified
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut
Gut microbiota and healthAlcohol Consumption and Health Effects
Cited by 618
- Verified
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 586
- Verified
Gut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut
Gut microbiota and healthLiver Disease and Transplantation
Cited by 525
- Verified
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 518
- Verified
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 506
- Verified
Calprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut
Inflammatory Bowel DiseaseS100 Proteins and Annexins
Cited by 500
- Verified
Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 482
- Verified
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Mantovani, A., Petracca, G., Beatrice, G., Tilg, H., Byrne, C. D., & Targher, G. (2021) · Gut
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 481
- Verified
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology
Gut microbiota and healthLiver Diseases and Immunity
Cited by 466
- Verified · note
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut
Liver Disease Diagnosis and TreatmentChronic Kidney Disease and Diabetes
Cited by 402
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free